Vivani Medical develops tiny semaglutide implant for lasting weight loss

Vivani Medical is developing a tiny implant containing semaglutide, the active ingredient in Novo Nordisk's Wegovy and Ozempic injections. The device is designed to help patients sustain weight loss without repeated injections. It represents one of the latest innovations in the rapidly expanding GLP-1 drug market.